New starch plant to be built in Rostov region for pharmaceutical and food industries
17 July 2024
In the city of Azov in the Rostov region, it is planned to build a plant for the deep processing of corn grain. The initial phase will necessitate an investment of approximately 40 billion rubles, with its launch set for the culmination of 2026. The project aims to achieve import substitution of starch, starch-containing products, food, and feed additives used in various industries such as food, pharmaceuticals, and confectionery.
Russia is to develop human vaccine against avian flu
17 July 2024
Scientific organizations in Russia have developed candidate flu vaccine viruses to prevent H5N1 avian flu in humans, according to the press service of Rospotrebnadzor. The decision to develop these medications was made based on recommendations from the WHO.
Equipment for hemodialysis will be produced in the Kaluga region
16 July 2024
In September 2024, the Russian pharmaceutical company Pharmasyntez will commence the construction of two factories in the Kaluga region. These sites will also host the production of import-substituting equipment for hemodialysis.
Russia and India will develop cooperation in drug development
16 July 2024
Drug development has emerged as a key focus area in the strategic roadmap of Russian-Indian economic cooperation until 2030. Moreover, both nations have pledged to foster close collaboration in the development and provision of cutting-edge medical equipment. This affirmation is outlined in the joint statement by the two leaders, Vladimir Putin and Narendra Modi, which has been featured on the official websites of the Indian Foreign Ministry and the Kremlin.
Since 2019, Russia registered 35 medical products with artificial intelligence
15 July 2024
Over the past five years, Roszdravnadzor has registered 35 medical products incorporating artificial intelligence (AI), 28 of which have been developed by 18 Russian innovators. Deputy Minister of Health Pavel Pugachev made this announcement during the round table discussion at the Federation Council focusing on “Legal regulation of the functioning of artificial intelligence systems in the Russian Federation: legislative development vector.”
Advanced techniques fuelling demand for liquid chromatography reagents
15 July 2024
The versatility of liquid chromatography is propelling demand for high-quality chromatography reagents, the report stated. A report published by Market Expertz predicts that size of the liquid chromatography reagents market will increase by $3,879.72 million between 2022 and 2032.
A GMP center for pharmacist students will be created in Tyumen
12 July 2024
The inter-university campus in the Tyumen region, established as part of the national project “Science and Universities” and overseen by the Ministry of Education and Science of the Russian Federation, is set to become a remarkable platform for training skilled personnel in the pharmaceutical industry. Alexander Moor, the head of the region, has shared that a visionary BioTechPharm school will be established on this campus to fulfill this purpose.
Medical glass plant to be established in Rostov
12 July 2024
The Deputy Governor of the Rostov Region, Igor Sorokin, and the project manager of Alfa Pharm Glass LLC, Konstantin Nikulnikov, have signed an agreement to establish production facilities for medical products made from borosilicate glass in the Rostov Region. The estimated cost of the first stage of construction is 1.6 billion rubles. This decision was made during the international exhibition “Innoprom-2024” held in Yekaterinburg.
Price set for Russian drug to treat Alzheimer’s and dementia
11 July 2024
The Federal Antimonopoly Service (FAS) of Russia has agreed on prices for the domestic generic drug Rivastigmine-ET (rivastigmine). The department’s press service has reported that the cost of the foreign reference drug Exelon has been reduced by an average of 11% compared to the registered prices.
Indian company Polymed is localizing the production of hemodialysis products in Russia
10 July 2024
The Russian Direct Investment Fund (RDIF) and Poly Medicure Limited (Polymed), an Indian medical device manufacturer, have reached a partnership agreement to establish local production of hemodialysis products in Russia. The volume of investment in the project from RDIF and partners is up to 3 billion rubles.
Vaccination against the plague using a Russian drug is currently being carried out in Mongolia
24 July 2024
24 July 2024
Russia will conduct an experiment to block the supply of low-quality products to hospitals
23 July 2024
With seventh person seemingly cured of HIV, signs of hope for a broader cure
23 July 2024